Kangmei Pharma | 600518 - Market Capitalization

Stock Price
1.88
Daily Change
0.01 0.53%
Monthly
-1.57%
Yearly
-14.93%
Q1 Forecast
1.84

Kangmei Pharma reported CNY26.06B in Market Capitalization this March of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Akebia Therapeutics USD 502M 75M Mar/2025
Alaunos Therapeutics USD 5M 2M Sep/2025
Avita Medical AUD 105.47M 35.32M Dec/2025
Cspc Pharmaceutical CNY 107.03B 26.09B Sep/2025
Dianthus Therapeutics USD 1.57B 967M Sep/2025
Genomma Lab Internacional MXN 17.89B 1.35B Dec/2025
Hypermarcas BRL 14.22B 3.01B Sep/2025
Ionis Pharmaceuticals USD 12.81B 2.39B Dec/2025
IQVIA Holdings USD 38.39B 6.1B Dec/2025
Jiangsu Hengrui CNY 477.39B 133.64B Sep/2025
Kangmei Pharma CNY 27.93B 1.73B Sep/2025
Organon & Co USD 1.86B 916.43M Dec/2025
Revvity USD 10.97B 1.21B Dec/2025
Sh Fosun Pharma CNY 75.97B 14.49B Sep/2025
Tectonic Therapeutic USD 294M 77M Sep/2025
Viatris USD 14.34B 2.8B Dec/2025
Wuxi Apptec CNY 330.55B 129.92B Sep/2025
Xeris Pharmaceuticals USD 1.32B 562M Sep/2025
Zz Pientze Pharmaceu CNY 118.73B 1.94B Sep/2025